Bio-Rad Laboratories, Inc. (BIO)
NYSE: BIO · IEX Real-Time Price · USD
267.55
+3.58 (1.36%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Bio-Rad Laboratories Revenue
Bio-Rad Laboratories had revenue of $2.61B in the twelve months ending March 31, 2024, down -6.25% year-over-year. Revenue in the quarter ending March 31, 2024 was $610.82M, a -9.75% decrease year-over-year. In the year 2023, Bio-Rad Laboratories had annual revenue of $2.67B, a decrease of -4.67%.
Revenue (ttm)
$2.61B
Revenue Growth
-6.25%
P/S Ratio
2.93
Revenue / Employee
$324,438
Employees
8,030
Market Cap
7.64B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.67B | -130.99M | -4.67% |
Dec 31, 2022 | 2.80B | -120.30M | -4.12% |
Dec 31, 2021 | 2.92B | 376.92M | 14.81% |
Dec 31, 2020 | 2.55B | 233.97M | 10.12% |
Dec 31, 2019 | 2.31B | 22.24M | 0.97% |
Dec 31, 2018 | 2.29B | 129.26M | 5.98% |
Dec 31, 2017 | 2.16B | 91.98M | 4.45% |
Dec 31, 2016 | 2.07B | 48.73M | 2.41% |
Dec 31, 2015 | 2.02B | -155.60M | -7.15% |
Dec 31, 2014 | 2.18B | 42.35M | 1.99% |
Dec 31, 2013 | 2.13B | 63.46M | 3.07% |
Dec 31, 2012 | 2.07B | -4.29M | -0.21% |
Dec 31, 2011 | 2.07B | 146.41M | 7.60% |
Dec 31, 2010 | 1.93B | 142.87M | 8.01% |
Dec 31, 2009 | 1.78B | 19.88M | 1.13% |
Dec 31, 2008 | 1.76B | 303.31M | 20.76% |
Dec 31, 2007 | 1.46B | 187.12M | 14.69% |
Dec 31, 2006 | 1.27B | 92.95M | 7.87% |
Dec 31, 2005 | 1.18B | 90.97M | 8.35% |
Dec 31, 2004 | 1.09B | 110.38M | 11.27% |
Dec 31, 2003 | 979.63M | 114.63M | 13.25% |
Dec 31, 2002 | 865.01M | 47.50M | 5.81% |
Dec 31, 2001 | 817.51M | 91.63M | 12.62% |
Dec 31, 2000 | 725.88M | 170.49M | 30.70% |
Dec 31, 1999 | 555.40M | 107.54M | 24.01% |
Dec 31, 1998 | 447.86M | 20.95M | 4.91% |
Dec 31, 1997 | 426.91M | 8.13M | 1.94% |
Dec 31, 1996 | 418.79M | 22.17M | 5.59% |
Dec 31, 1995 | 396.62M | 41.32M | 11.63% |
Dec 31, 1994 | 355.30M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Henry Schein | 12.45B |
Exact Sciences | 2.53B |
Chemed | 2.29B |
HealthEquity | 1.04B |
Intra-Cellular Therapies | 513.93M |
Ascendis Pharma | 357.63M |
Legend Biotech | 342.80M |
Roivant Sciences | 124.80M |
BIO News
- 4 weeks ago - Bio-Rad Names Anette Engelhardt Executive Vice President and President of Clinical Diagnostics Group - Business Wire
- 5 weeks ago - Bio-Rad's Management to Participate in Fireside Chat During Jefferies Global Healthcare Conference - Business Wire
- 2 months ago - Bio-Rad Laboratories reiterates 2024 revenue growth outlook; shares slip - Reuters
- 2 months ago - Bio-Rad Reports First-Quarter 2024 Financial Results - Business Wire
- 2 months ago - Bio-Rad's Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare Conference - Business Wire
- 2 months ago - Bio-Rad Announces Life Science Group Management Changes - Business Wire
- 2 months ago - Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024 - Business Wire
- 2 months ago - Bio-Rad's Chief Operating Officer Andrew Last to Retire - Business Wire